Navigation Links
Early On, Hormone Therapy May Raise Women's Heart Risks
Date:2/18/2010

Study reports little coronary benefit, regardless of when treatment begins

THURSDAY, Feb. 18 (HealthDay News) -- Hormone replacement therapy does not lower the odds of heart trouble in women who take the regimen to ease hot flashes and other symptoms of menopause, a new study reports.

In fact, the researchers say, it will probably elevate the risk for heart attacks for the first two years of use.

"There was no protective effect after women first started hormone therapy," said Dr. James Liu, chairman of obstetrics and gynecology at MacDonald Women's Hospital in Cleveland, who was not involved with the study. "There may be some benefit later on, but it's subtle," he added.

The study reported that women who started taking hormone therapy within 10 years of menopause and who had been taking it for six years might derive some heart-protective effects, but the protection did not reach statistical significance.

No protection was found for women who started hormone therapy at least 10 years after menopause.

The findings, published in the Feb. 15 issue of Annals of Internal Medicine, do not change any current recommendations regarding the widely debated use of hormone therapy, the researchers said.

"If women are thinking about using hormone therapy for menopausal symptoms, they should use the lowest dose and for the shortest duration possible," said the study's lead author, Sengwee Darren Toh, an instructor in population medicine at Harvard Medical School in Boston. Toh worked at the Harvard School of Public Health when the study was conducted.

The findings stem from a new analysis of data from the Women's Health Initiative (WHI), a large, government-sponsored study. Earlier reports from the WHI showed an overall elevated risk for coronary heart disease among women taking estrogen-plus-progestin therapy, called combined hormone therapy.

However, much debate has circulated around whether the risk differs depending on when women start taking the therapy in relation to when they entered menopause.

The so-called "timing hypothesis" has postulated that heightened risk might not exist for women at the younger end of the spectrum.

Originally, the WHI data was analyzed according to the number of women assigned to each arm -- whether they were taking hormones or placebos -- and did not take into account people who stopped taking the therapy or who crossed over to another arm, Liu explained.

And about 40 percent of the 16,000-plus women participating in the part of the study examining hormone use did not take their assigned treatment, a proportion that increased over time.

"We need to account for this noncompliance if we want to estimate how the effects of hormone therapy on coronary heart disease change over time," Toh said.

In their analysis, Toh and his colleagues found that, overall, women who took combined hormone therapy for the first two years of the study had more than double the risk for heart attack and other coronary problems.

The increased risk was 69 percent among those taking hormone therapy for eight years.

Among women who started hormone therapy within a decade of menopause, the risk was raised just 29 percent, not considered statistically significant. Over the first eight years of use, the risk for heart attacks was 36 percent lower in this group, the study reported.

"Our paper suggests that both timing of initiating and time since initiation are important aspects to consider when we discuss the effects of hormone therapy on heart disease risk," Toh said.

More information

The U.S. National Women's Health Information Center has more on heart disease in women.



SOURCES: Sengwee Darren Toh, Sc.D., instructor, population medicine, Harvard Medical School, Boston; James Liu, M.D., chairman, department of obstetrics and gynecology, MacDonald Women's Hospital, University Hospitals, Case Western Reserve University, Cleveland; Feb. 15, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pot bellies linked to early signs of cardiovascular disease
2. Eye-staining technique offers early detection for dry eye syndrome
3. Early Weight Loss in Women Linked to Dementia
4. Isolation of a new gene family essential for early development
5. U of M study: Early treatment can reverse heart damage
6. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Pop stars more than twice as likely to die an early death
9. Exercise and yoga improves quality of life in women with early-stage breast cancer
10. Research says doctors gender may hinder early diagnosis of heart disease in women
11. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2017)... ... 2017 , ... Viewers likely know Rob Lowe from such 80s hits as ... his work on NBC’s The West Wing and Parks and Recreation. But recently, Lowe’s ... which puts the spotlight on important modern-day issues that face today’s society. One of ...
(Date:5/27/2017)... ... 2017 , ... From May 21-23, hearing healthcare professionals gained a competitive edge ... the Marriott Syracuse Downtown Hotel in Syracuse, New York. , As EarQ’s technology ... healthcare providers to help them stay ahead in the industry. At the event, EarQ ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, ... and 31st at The Four Seasons Hotel Boston. , The Boston CEO ... offering exclusive access to key decision makers who influence deal making and investment. ...
(Date:5/26/2017)... ... ... A new analysis of community health data reveals that four out of the ... the average cost of healthcare rising and the U.S. senior population expected to double ... of where they live. An annual 2017 report looked at a variety of community ...
(Date:5/26/2017)... ... 2017 , ... After raising nearly $30,000 on Kickstarter , about three-times ... at a discounted crowdfunding price on Indiegogo . , “Along with creating an ... to bring a fidget toy to the market that was made of superior quality ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
(Date:5/10/2017)... , May 10, 2017 Radiology has become ... its costs have also spiraled to the number one ... to radiology than ever before as the most complete ... a patient with lower back pain an MRI may ... reason for pain, resulting in entirely different treatment protocols.  ...
(Date:5/9/2017)... May 9, 2017  Demonstrating its commitment to ... directors for the Pharmaceutical Research and Manufacturers of ... Biopharmaceutical companies will now have to meet new ... be eligible to join PhRMA. "By ... is sending a clear message that being a ...
Breaking Medicine Technology: